MAIA Biotechnology, Inc. MAIA
1.20
(0.05)
(4.00%)
as of 25 Sep
- Market cap
- $76.0M
- P/E
- 0.0×
Follow MAIA
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|
Current Ratio |
1.66 | 2.65 | 1.53 | 3.61 | 4.97 | 0.44 | 4.63 |
Net Debt/EBITDA |
0.36 | 0.57 | 0.35 | 0.68 | 1.47 | 0.01 | 0.24 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 79.14% | 2.03% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.18) | (0.20) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.84 | 0.68 | 0.66 | 0.75 | 0.33 | 0.28 | 0.24 |
Capex/Depreciation |
— | — | — | — | 0.00 | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (745.24%) | (1,131.04%) | (440.12%) | (183.39%) | (427.84%) | 378.27% | 0.00% | |
| (225.54%) | (262.44%) | (201.88%) | (138.93%) | (207.13%) | (535.00%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(579.39%) | (367.81%) | (752.71%) | (189.95%) | (146.65%) | 700.67% | (477.45%) |
Average Days of Receivables |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Free Cash Flow per Share |
(0.59) | (0.71) | (0.99) | (1.30) | (0.78) | (0.17) | (0.15) |
Cash per Share |
0.27 | 0.43 | 0.54 | 1.18 | 2.00 | 0.06 | 0.16 |
Shareholders Equity per Share |
0.07 | 0.16 | 0.04 | 0.92 | 1.74 | (0.31) | (0.02) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.07 | 0.16 | 0.04 | 0.92 | 1.74 | (0.31) | (0.02) |
Free Cash Flow |
(18.84) | (15.70) | (13.07) | (12.10) | (4.12) | (1.84) | (1.57) |
Working Capital |
3.87 | 6.32 | 2.63 | 8.54 | 8.53 | (0.95) | 1.36 |
Net Current Asset Value |
2.37 | 3.63 | 0.47 | 8.29 | 8.53 | (1.62) | 1.32 |
| Other line items | |||||||
Quick Ratio |
1.48 | 2.53 | 1.48 | 3.44 | 4.95 | 0.39 | 4.56 |
Depreciation/Fixed assets |
— | — | — | — | 0.00 | — | — |
Cash ROIC |
(170.79%) | (118.65%) | (171.35%) | (62.16%) | (20.87%) | 88.59% | (99.57%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | 0.00 | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.59) | (0.71) | (0.99) | (1.30) | (0.78) | (0.17) | (0.15) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 0.11 | 0.22 | 0.17 | — | — | — |
Average Payables |
1.78 | 1.58 | 1.40 | 1.06 | 0.58 | 0.19 | — |
Average Assets |
9.93 | 8.86 | 9.79 | 11.67 | 6.04 | 1.24 | — |
Average Common Equity |
3.01 | 2.06 | 4.49 | 8.84 | 2.92 | (1.75) | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates